Results of Celsion’s OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research
Go back to Results of Celsion’s OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research| CELSION (NASDAQ: CLSN) | Delayed: 1.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $2.31 | |||
| Open | $1.96 | 52 Week Low | $0.82 | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.96 | EPS | $-1.79 | |||
| Volume | 278,710 | |||||
